{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:12:45Z","timestamp":1790291565591,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["SFARI 9900060"],"award-info":[{"award-number":["SFARI 9900060"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UC Davis RISE Award"},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50MH106438"],"award-info":[{"award-number":["P50MH106438"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Women exposed to a variety of viral and bacterial infections during pregnancy have an increased risk of giving birth to a child with autism, schizophrenia or other neurodevelopmental disorders. Preclinical maternal immune activation (MIA) models are powerful translational tools to investigate mechanisms underlying epidemiological links between infection during pregnancy and offspring neurodevelopmental disorders. Our previous studies documenting the emergence of aberrant behavior in rhesus monkey offspring born to MIA-treated dams extends the rodent MIA model into a species more closely related to humans. Here we present novel neuroimaging data from these animals to further explore the translational potential of the nonhuman primate MIA model. Nine male MIA-treated offspring and 4 controls from our original cohort underwent in vivo positron emission tomography (PET) scanning at approximately 3.5-years of age using [<jats:sup>18<\/jats:sup>F] fluoro-l-m-tyrosine (FMT) to measure presynaptic dopamine levels in the striatum, which are consistently elevated in individuals with schizophrenia. Analysis of [<jats:sup>18<\/jats:sup>F]FMT signal in the striatum of these nonhuman primates showed that MIA animals had significantly higher [<jats:sup>18<\/jats:sup>F]FMT index of influx compared to control animals. In spite of the modest sample size, this group difference reflects a large effect size (Cohen\u2019s <jats:italic>d<\/jats:italic>\u2009=\u20090.998). Nonhuman primates born to MIA-treated dams exhibited increased striatal dopamine in late adolescence\u2014a hallmark molecular biomarker of schizophrenia. These results validate the MIA model in a species more closely related to humans and open up new avenues for understanding the neurodevelopmental biology of schizophrenia and other neurodevelopmental disorders associated with prenatal immune challenge.<\/jats:p>","DOI":"10.1038\/s41398-019-0449-y","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T12:02:59Z","timestamp":1555070579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Preliminary evidence of increased striatal dopamine in a nonhuman primate model of maternal immune activation"],"prefix":"10.1038","volume":"9","author":[{"given":"Melissa D.","family":"Bauman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler A.","family":"Lesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Smucny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Kukis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon R.","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Kimberley","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron S.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneurol.2014.187","volume":"10","author":"I Knuesel","year":"2014","unstructured":"Knuesel, I. et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat. Rev. Neurol. 10, 643\u2013660 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1523\/JNEUROSCI.2272-17.2018","volume":"38","author":"MN Spann","year":"2018","unstructured":"Spann, M. N., Monk, C., Scheinost, D. & Peterson, B. S. Maternal immune activation during the third trimester is associated with neonatal functional connectivity of the salience network and fetal to toddler behavior. J. Neurosci. 38, 2877\u20132886 (2018).","journal-title":"J. Neurosci."},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41593-018-0128-y","volume":"21","author":"MD Rudolph","year":"2018","unstructured":"Rudolph, M. D. et al. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat. Neurosci. 21, 765\u2013772 (2018).","journal-title":"Nat. Neurosci."},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.neuroimage.2018.04.020","volume":"185","author":"JM Rasmussen","year":"2019","unstructured":"Rasmussen, J. M. et al. Maternal Interleukin-6 concentration during pregnancy is associated with variation in frontolimbic white matter and cognitive development in early life. NeuroImage 185, 825\u2013835, https:\/\/doi.org\/10.1016\/j.neuroimage.2018.04.020 (2019).","journal-title":"NeuroImage"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biopsych.2017.05.027","volume":"83","author":"AM Graham","year":"2018","unstructured":"Graham, A. M. et al. Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 years of age. Biol. Psychiatry 83, 109\u2013119 (2018).","journal-title":"Biol. Psychiatry"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1126\/science.aag3194","volume":"353","author":"ML Estes","year":"2016","unstructured":"Estes, M. L. & McAllister, A. K. Maternal immune activation: implications for neuropsychiatric disorders. Science 353, 772\u2013777 (2016).","journal-title":"Science"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.neuropharm.2011.01.009","volume":"62","author":"U Meyer","year":"2012","unstructured":"Meyer, U. & Feldon, J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62, 1308\u20131321 (2012).","journal-title":"Neuropharmacology"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41386-018-0185-7","volume":"44","author":"AC Kentner","year":"2019","unstructured":"Kentner, A. C. et al. Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. Neuropsychopharmacology 44, 245\u2013258, https:\/\/doi.org\/10.1038\/s41386-018-0185-7 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","volume":"90","author":"U Meyer","year":"2010","unstructured":"Meyer, U. & Feldon, J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Progress. Neurobiol. 90, 285\u2013326 (2010).","journal-title":"Progress. Neurobiol."},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopsych.2016.10.020","volume":"81","author":"M Careaga","year":"2017","unstructured":"Careaga, M., Murai, T. & Bauman, M. D. Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol. Psychiatry 81, 391\u2013401 (2017).","journal-title":"Biol. Psychiatry"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.biopsych.2013.07.011","volume":"75","author":"U Meyer","year":"2014","unstructured":"Meyer, U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 75, 307\u2013315 (2014).","journal-title":"Biol. Psychiatry"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nature.2016.20893","volume":"539","author":"A Abbott","year":"2016","unstructured":"Abbott, A. US mental-health chief: psychiatry must get serious about mathematics. Nature 539, 18\u201319 (2016).","journal-title":"Nature"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajp.22281","volume":"76","author":"KA Phillips","year":"2014","unstructured":"Phillips, K. A. et al. Why primate models matter. Am. J. Primatol. 76, 801\u2013827 (2014).","journal-title":"Am. J. Primatol."},{"issue":"Pt A","key":"449_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.expneurol.2017.07.021","volume":"299","author":"MD Bauman","year":"2018","unstructured":"Bauman, M. D. & Schumann, C. M. Advances in nonhuman primate models of autism: Integrating neuroscience and behavior. Exp. Neurol. 299(Pt A), 252\u2013265 (2018).","journal-title":"Exp. Neurol."},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbr.2010.12.023","volume":"219","author":"AA Willette","year":"2011","unstructured":"Willette, A. A. et al. Brain enlargement and increased behavioral and cytokine reactivity in infant monkeys following acute prenatal endotoxemia. Behav. brain Res. 219, 108\u2013115 (2011).","journal-title":"Behav. brain Res."},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.biopsych.2009.11.026","volume":"67","author":"SJ Short","year":"2010","unstructured":"Short, S. J. et al. Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol. Psychiatry 67, 965\u2013973 (2010).","journal-title":"Biol. Psychiatry"},{"key":"449_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.biopsych.2013.06.025","volume":"75","author":"MD Bauman","year":"2014","unstructured":"Bauman, M. D. et al. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol. Psychiatry 75, 332\u2013341 (2014).","journal-title":"Biol. Psychiatry"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbi.2016.11.020","volume":"63","author":"DR Rose","year":"2017","unstructured":"Rose, D. R. et al. Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation. Brain, Behav., Immun. 63, 60\u201370 (2017).","journal-title":"Brain, Behav., Immun."},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.biopsych.2014.07.035","volume":"77","author":"CJ Machado","year":"2015","unstructured":"Machado, C. J., Whitaker, A. M., Smith, S. E., Patterson, P. H. & Bauman, M. D. Maternal immune activation in nonhuman primates alters social attention in juvenile offspring. Biol. Psychiatry 77, 823\u2013832 (2015).","journal-title":"Biol. Psychiatry"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1176\/appi.ajp.2018.17121311","volume":"175","author":"AS Brown","year":"2018","unstructured":"Brown, A. S. & Meyer, U. Maternal immune activation and neuropsychiatric illness: a translational research perspective. Am. J. Psychiatry 175, 1073\u20131083, https:\/\/doi.org\/10.1176\/appi.ajp.2018.17121311 (2018).","journal-title":"Am. J. Psychiatry"},{"key":"449_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.6","volume":"2","author":"D Eyles","year":"2012","unstructured":"Eyles, D., Feldon, J. & Meyer, U. Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl. Psychiatry 2, e81 (2012).","journal-title":"Transl. Psychiatry"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","volume":"30","author":"S Vuillermot","year":"2010","unstructured":"Vuillermot, S., Weber, L., Feldon, J. & Meyer, U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J. Neurosci. : Off. J. Soc. Neurosci. 30, 1270\u20131287 (2010).","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","volume":"28","author":"L Zuckerman","year":"2003","unstructured":"Zuckerman, L., Rehavi, M., Nachman, R. & Weiner, I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28, 1778\u20131789 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","volume":"59","author":"K Ozawa","year":"2006","unstructured":"Ozawa, K. et al. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 59, 546\u2013554 (2006).","journal-title":"Biol. Psychiatry"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","volume":"206","author":"U Meyer","year":"2009","unstructured":"Meyer, U. & Feldon, J. Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology 206, 587\u2013602 (2009).","journal-title":"Psychopharmacology"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biopsych.2016.03.2104","volume":"81","author":"JJ Weinstein","year":"2017","unstructured":"Weinstein, J. J. et al. Pathway-Specific Dopamine Abnormalities in Schizophrenia. Biol. Psychiatry 81, 31\u201342 (2017).","journal-title":"Biol. Psychiatry"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.09.005","volume":"75","author":"KN Murray","year":"2019","unstructured":"Murray, K. N. et al. Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects. Brain. Behav. Immun 75, 48\u201359, https:\/\/doi.org\/10.1016\/j.bbi.2018.09.005 (2019).","journal-title":"Brain. Behav. Immun"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.apradiso.2004.04.008","volume":"61","author":"HF VanBrocklin","year":"2004","unstructured":"VanBrocklin, H. F. et al. A new precursor for the preparation of 6-[18F]Fluoro-L-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling. Appl Radiat Isot. 61, 1289\u20131294 (2004).","journal-title":"Appl Radiat Isot."},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/0024-3205(95)00147-X","volume":"56","author":"GL Chan","year":"1995","unstructured":"Chan, G. L. et al. Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa\/PET scans in non-human primates. Life Sci. 56, 1759\u20131766 (1995).","journal-title":"Life Sci."},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0197-4580(01)00323-2","volume":"23","author":"JL Eberling","year":"2002","unstructured":"Eberling, J. L. et al. No effect of age and estrogen on aromatic L- amino acid decarboxylase activity in rhesus monkey brain. Neurobiol. Aging 23, 479\u2013483 (2002).","journal-title":"Neurobiol. Aging"},{"key":"449_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0041-008X(74)90055-6","volume":"29","author":"RE Zwickey","year":"1974","unstructured":"Zwickey, R. E. et al. Preclinical toxicological studies of carbidopa and combinations of carbidopa and levodopa. Toxicol. Appl. Pharmacol. 29, 181\u2013195 (1974).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0024-3205(90)90228-J","volume":"47","author":"WP Melega","year":"1990","unstructured":"Melega, W. P. et al. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. Life Sci. 47, 149\u2013157 (1990).","journal-title":"Life Sci."},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00004647-199903000-00006","volume":"19","author":"DJ Doudet","year":"1999","unstructured":"Doudet, D. J. et al. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine. J. Cereb. Blood Flow Metab. 19, 278\u2013287 (1999).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1088\/0031-9155\/46\/7\/308","volume":"46","author":"C Tai","year":"2001","unstructured":"Tai, C. et al. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys. Med. Biol. 46, 1845\u20131862 (2001).","journal-title":"Phys. Med. Biol."},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.WCB.0000050041.22945.3E","volume":"23","author":"V Sossi","year":"2003","unstructured":"Sossi, V., Holden, J. E., de la Fuente-Fernandez, R., Ruth, T. J. & Stoessl, A. J. Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki. J. Cereb. Blood Flow Metab. 23, 301\u2013309 (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"449_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak, C. S. & Blasberg, R. G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 5, 584\u2013590 (1985).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"449_CR37","unstructured":"Paxinos G., Huang X., Petrides M., Toga A. The rhesus monkey brain in stereotaxic coordinates. (Academic Press, San Diego, 2008)."},{"key":"449_CR38","unstructured":"Saleem K. S., Logothetis N. K. A Combined MRI and Histology Atlas of the Rhesus Monkey Brain in Stereotaxic Coordinates, 2nd edn (Academic Press, San Diego 2012)."},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich, P. A. et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 31, 1116\u20131128 (2006).","journal-title":"NeuroImage"},{"key":"449_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/1098-2396(200008)37:2<81::AID-SYN1>3.0.CO;2-#","volume":"37","author":"OG Rousset","year":"2000","unstructured":"Rousset, O. G. et al. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects. Synapse 37, 81\u201389 (2000).","journal-title":"Synapse"},{"key":"449_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.neuropharm.2011.04.019","volume":"62","author":"Y Piontkewitz","year":"2012","unstructured":"Piontkewitz, Y., Arad, M. & Weiner, I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 62, 1273\u20131289 (2012).","journal-title":"Neuropharmacology"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.npp.1301413","volume":"33","author":"U Meyer","year":"2008","unstructured":"Meyer, U. et al. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33, 441\u2013456 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"449_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0125-0","volume":"8","author":"S Vuillermot","year":"2017","unstructured":"Vuillermot, S., Luan, W., Meyer, U. & Eyles, D. Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation. Mol. Autism 8, 9 (2017).","journal-title":"Mol. Autism"},{"key":"449_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28090-w","volume":"8","author":"W Luan","year":"2018","unstructured":"Luan, W., Hammond, L. A., Vuillermot, S., Meyer, U. & Eyles, D. W. Maternal vitamin D prevents abnormal dopaminergic development and function in a mouse model of prenatal immune activation. Sci. Rep. 8, 9741 (2018).","journal-title":"Sci. Rep."},{"key":"449_CR45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopsych.2018.09.010","volume":"85","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon, R. A. et al. Mesolimbic dopamine function is related to salience network connectivity: an integrative positron emission tomography and magnetic resonance study. Biological Psychiatry 85, 368\u2013378, https:\/\/doi.org\/10.1016\/j.biopsych.2018.09.010 (2019).","journal-title":"Biological Psychiatry"},{"key":"449_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone, J. D. & Correa, M. The mysterious motivational functions of mesolimbic dopamine. Neuron 76, 470\u2013485 (2012).","journal-title":"Neuron"},{"key":"449_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn.2017.130","volume":"18","author":"ND Volkow","year":"2017","unstructured":"Volkow, N. D., Wise, R. A. & Baler, R. The dopamine motive system: implications for drug and food addiction. Nat. Rev. Neurosci. 18, 741\u2013752 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"449_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","volume":"72","author":"M Goodkind","year":"2015","unstructured":"Goodkind, M. et al. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72, 305\u2013315 (2015).","journal-title":"JAMA Psychiatry"},{"key":"449_CR49","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1176\/appi.ajp.2017.16040400","volume":"174","author":"LM McTeague","year":"2017","unstructured":"McTeague, L. M. et al. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am. J. Psychiatry 174, 676\u2013685 (2017).","journal-title":"Am. J. Psychiatry"},{"key":"449_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/schbul\/sbr180","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli, P. & Meyer-Lindenberg, A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F\/(11)C]-DOPA PET studies. Schizophr. Bull. 39, 33\u201342 (2013).","journal-title":"Schizophr. Bull."},{"key":"449_CR51","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes, O. D. et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. General. Psychiatry 69, 776\u2013786 (2012).","journal-title":"Arch. General. Psychiatry"},{"key":"449_CR52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(95)91801-9","volume":"346","author":"J Hietala","year":"1995","unstructured":"Hietala, J. et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346, 1130\u20131131 (1995).","journal-title":"Lancet"},{"key":"449_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr. Bull. 35, 549\u2013562 (2009).","journal-title":"Schizophr. Bull."},{"key":"449_CR54","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1523\/JNEUROSCI.0805-07.2007","volume":"27","author":"Y Kumakura","year":"2007","unstructured":"Kumakura, Y. et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa\/positron emission tomography study. J. Neurosci. : Off. J. Soc. Neurosci. 27, 8080\u20138087 (2007).","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"449_CR55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0006-3223(99)00109-2","volume":"46","author":"LH Lindstrom","year":"1999","unstructured":"Lindstrom, L. H. et al. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol. Psychiatry 46, 681\u2013688 (1999).","journal-title":"Biol. Psychiatry"},{"key":"449_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/archpsyc.61.2.134","volume":"61","author":"S McGowan","year":"2004","unstructured":"McGowan, S., Lawrence, A. D., Sales, T., Quested, D. & Grasby, P. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. Arch. General. Psychiatry 61, 134\u2013142 (2004).","journal-title":"Arch. General. Psychiatry"},{"key":"449_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nn804","volume":"5","author":"A Meyer-Lindenberg","year":"2002","unstructured":"Meyer-Lindenberg, A. et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5, 267\u2013271 (2002).","journal-title":"Nat. Neurosci."},{"key":"449_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2008.11.006","volume":"108","author":"S Nozaki","year":"2009","unstructured":"Nozaki, S. et al. Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. Schizophr. Res. 108, 78\u201384 (2009).","journal-title":"Schizophr. Res."},{"key":"449_CR59","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","volume":"91","author":"J Reith","year":"1994","unstructured":"Reith, J. et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl Acad. Sci. USA. 91, 11651\u201311654 (1994).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"449_CR60","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/schbul\/sbx180","volume":"44","author":"R McCutcheon","year":"2018","unstructured":"McCutcheon, R., Beck, K., Jauhar, S. & Howes, O. D. Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. Schizophr. Bull. 44, 1301\u20131311 (2018).","journal-title":"Schizophr. Bull."},{"key":"449_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","volume":"66","author":"OD Howes","year":"2009","unstructured":"Howes, O. D. et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. General. Psychiatry 66, 13\u201320 (2009).","journal-title":"Arch. General. Psychiatry"},{"key":"449_CR62","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","volume":"168","author":"OD Howes","year":"2011","unstructured":"Howes, O. D. et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am. J. Psychiatry 168, 1311\u20131317 (2011).","journal-title":"Am. J. Psychiatry"},{"key":"449_CR63","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha, A., Murray, R. M., McGuire, P. K., Kapur, S. & Howes, O. D. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am. J. Psychiatry 169, 1203\u20131210 (2012).","journal-title":"Am. J. Psychiatry"},{"key":"449_CR64","doi-asserted-by":"publisher","unstructured":"Jauhar S., et al. Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study. Mol. Psychiatry, https:\/\/doi.org\/10.1038\/s41380-018-0042-4. (2018).","DOI":"10.1038\/s41380-018-0042-4"},{"key":"449_CR65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.schres.2016.06.005","volume":"176","author":"A Egerton","year":"2016","unstructured":"Egerton, A. et al. Adversity in childhood linked to elevated striatal dopamine function in adulthood. Schizophr. Res. 176, 171\u2013176 (2016).","journal-title":"Schizophr. Res."},{"key":"449_CR66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/schbul\/sbx023.081","volume":"43","author":"A Egerton","year":"2017","unstructured":"Egerton, A. et al. Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis. Schizophr. Bull. 43, 293\u2013301 (2017).","journal-title":"Schizophr. Bull."},{"key":"449_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.09.003","volume":"95","author":"V Bonapersona","year":"2018","unstructured":"Bonapersona, V., Joels, M. & Sarabdjitsingh, R. A. Effects of early life stress on biochemical indicators of the dopaminergic system: A 3 level meta-analysis of rodent studies. Neurosci. Biobehav. Rev. 95, 1\u201316 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"449_CR68","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1126\/science.1228261","volume":"339","author":"S Giovanoli","year":"2013","unstructured":"Giovanoli, S. et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339, 1095\u20131099 (2013).","journal-title":"Science"},{"key":"449_CR69","doi-asserted-by":"publisher","first-page":"87ps24","DOI":"10.1126\/scitranslmed.3001628","volume":"3","author":"P Bacchetti","year":"2011","unstructured":"Bacchetti, P., Deeks, S. G. & McCune, J. M. Breaking free of sample size dogma to perform innovative translational research. Sci. Transl. Med. 3, 87ps24 (2011).","journal-title":"Sci. Transl. Med."},{"key":"449_CR70","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/nn.2691","volume":"13","author":"ES Rosenzweig","year":"2010","unstructured":"Rosenzweig, E. S. et al. Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat. Neurosci. 13, 1505\u20131510 (2010).","journal-title":"Nat. Neurosci."},{"key":"449_CR71","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nm.4502","volume":"24","author":"ES Rosenzweig","year":"2018","unstructured":"Rosenzweig, E. S. et al. Restorative effects of human neural stem cell grafts on the primate spinal cord. Nature medicine 24, 484\u2013490 (2018).","journal-title":"Nature medicine"},{"key":"449_CR72","doi-asserted-by":"publisher","first-page":"18037","DOI":"10.1073\/pnas.1420167111","volume":"111","author":"R Landman","year":"2014","unstructured":"Landman, R., Sharma, J., Sur, M. & Desimone, R. Effect of distracting faces on visual selective attention in the monkey. Proc. Natl Acad. Sci. USA. 111, 18037\u201318042 (2014).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"449_CR73","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1073\/pnas.1114621109","volume":"109","author":"SW Chang","year":"2012","unstructured":"Chang, S. W., Barter, J. W., Ebitz, R. B., Watson, K. K. & Platt, M. L. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta). Proc. Natl Acad. Sci. USA. 109, 959\u2013964 (2012).","journal-title":"Proc. Natl Acad. Sci. USA."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0449-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T15:33:15Z","timestamp":1671204795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-019-0449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1038\/s41398-019-0449-y","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"135"}}